BRCAAWAY Trial: Abiraterone and Olapa... - Advanced Prostate...

Advanced Prostate Cancer

21,056 members26,262 posts

BRCAAWAY Trial: Abiraterone and Olaparib work way better together than sequentially in mCRPC for BRCA1/2 and ATM

Maxone73 profile image
2 Replies

"The median progression-free survival was 39 months. So this is over three years median compared to the abiraterone arm, which was about eight and a half months, and then 14 months for the olaparib. "

urotoday.com/video-lectures...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Jewelrylady profile image
Jewelrylady

thank you for sharing this. Can you also be on Lupron + abiraterone + prednisone for the olaparib to be added if you became castrate resistant.

Maxone73 profile image
Maxone73 in reply to Jewelrylady

I suppose so but this trial was not about that combination

You may also like...

Abiraterone + Olaparib: ASCO GU 2024 Highlights: BRCAAway Trial

\\" 39 months progression free is not bad at all......

Lynparza (olaparib) +Zytiga (abiraterone) better than Zytiga alone for mCRPC regardless of BRCA status

benefit is in radiographic progression-free survival. No numbers yet....

Abiraterone/enzalutamide+PARP inhibitor better than abiraterone/enzalutamide alone for mCRPC, even without BRCA+

(talazoparib)) with either abiraterone or enzalutamide, cancer progression was slowed, even in men...

Lynparza (olaparib) slows progression in men with BRCA2, BRCA1, and ATM gene mutations

Zejula (niraparib): https://pcnrv.blogspot.com/2019/10/olaparib-slows-progression-in-men-with.html

PARP treatment for BRCA2-2nd gen better than Olaparib?

BRCA2 positive. Have been on Olaparib for 9 months. Great results as PSA undectable for past 7....